---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027744"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:12:36.117411+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Director Jeffrey Fink resigns from Lipocine Board effective Jan 1, 2026

## Summary
- Jeffrey Fink informed the Board on Dec 12, 2025 of his resignation effective Jan 1, 2026 for personal reasons.
- Resignation not due to any disagreement with the Company on any matter.
- Board intends to conduct a search for a new director.

## SEC filing metadata
- accession: 0001493152-25-027744
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/0001493152-25-027744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027744
- JSON: https://secwatch.observer/filing/0001493152-25-027744.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027744.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.